Vicky Kang, MD
About Vicky Kang, MD
Vicky Kang, MD, serves as the Medical Director of Clinical Development at Mirati Therapeutics and Seagen, bringing extensive medical expertise to both roles since 2020 and 2021, respectively.
Work at Mirati Therapeutics
Vicky Kang serves as the Medical Director of Clinical Development at Mirati Therapeutics, a position she has held since 2021. In this role, she is responsible for overseeing clinical development strategies and ensuring the successful advancement of therapeutic programs. Her contributions are integral to the company's mission of developing innovative treatments for cancer.
Work at Seagen
In addition to her role at Mirati Therapeutics, Vicky Kang has been working at Seagen as the Medical Director of Clinical Development since 2020. Her responsibilities include leading clinical development efforts and collaborating with cross-functional teams to drive the development of targeted therapies for cancer. Her experience in this position complements her work at Mirati Therapeutics.
Education and Expertise
Vicky Kang earned her Doctor of Medicine (MD) degree from Rush Medical College of Rush University Medical Center. Prior to this, she completed a Bachelor of Science (BS) at New York University, where she studied Psychology, Economics, East Asian Studies, and Chemistry. Additionally, she underwent Plastic and Reconstructive Surgery Residency at the University of California, Los Angeles, which further enhances her medical expertise.
Background
Vicky Kang has a diverse educational background that includes a strong foundation in both the sciences and humanities. Her studies in Psychology, Economics, East Asian Studies, and Chemistry at New York University provide her with a broad perspective that informs her clinical development work. Her medical training and residency have equipped her with specialized skills in surgery and patient care.